Services: Diversified Services

Genetic Technologies Ltd (GENE: NASDAQ)

$0.948 n/a | n/a%
07/23/14 - 03:59 PM ET
Company Cash Flow
Jun 2013 Jun 2012 Jun 2011 Jun 2010
Cash Flow From Operating Activities
Net Income (Loss) -8.68M -5.42M 963.32K -7.95M
Operating Gains/Losses 405.49K -5.28M 305.45K -181.71K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables 155.27K 182.69K 85.81K 913.26K
(Increase) Decrease in Inventories 0.00 0.00 0.00 0.00
(Increase) Decrease In Other Current Assets -178.00K -15.17K 0.00 0.00
(Decrease) Increase In Payables 435.89K -214.30K -86.19K -818.33K
(Decrease) Increase In Other Current Liabilities 14.83K 0.00 -33.02K -29.38K
(Increase) Decrease In Other Working Capital 50.23K 194.72K 44.67K -328.91K
Other Non-Cash Items 319.28K 2.18M 558.81K 1.52M
Net Cash From Continuing Operations -6.97M -7.86M 2.39M -3.66M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities -6.97M -7.86M 2.39M -3.66M
Sale of Property, Plant & Equipment 1.11K 32.21K 154.66K 4.23K
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 0.00 0.00
Purchases of Property, Plant & Equipment -49.74K -78.15K -149.28K -329.05K
Acquisitions -117.14K 10.00 0.00 -809.48K
Purchases of Short-Term Investments 0.00 0.00 0.00 0.00
Other Cash from Investing Activities 0.00 549.97K 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -165.77K 504.04K 5.38K -883.42K
Issuance of Debt 0.00 1.02M 0.00 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 446.78K 11.16M 0.00 859.77K
Repayment of Long-Term Debt -16.47K -1.08M -336.41K -191.57K
Repurchase of Capital Stock 0.00 0.00 0.00 0.00
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -23.94K 0.00 0.00 0.00
Net Cash From Financing Activities 406.38K 11.11M -336.41K 668.20K
Effect of Exchange Rate Changes 72.87K 129.54K -133.80K 30.20K
Net Change in Cash & Cash Equivalents -6.66M 3.89M 1.92M -3.84M

Portfolios with GENE

Latest GENE Headlines from TheStreet

More Financial News for GENE

Press Releases for GENE

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter